Practical Implications—Nurses Caring for Patients with Osteoporosis
DOI:
https://doi.org/10.37628/ijorn.v6i1.1488Abstract
Osteoporosis is a major health problem worldwide. This porous bone develops due to weak bone density that tends to fracture from a slip or fall. Despite the serious consequences, many people are unaware of its early symptoms, preventive actions and management. Nurses have a major role in assessing, educating and preventing osteoporosis. This article reviews the current updates of osteoporosis within the scope of nursing practice.
References
International Osteoporosis Foundation (IOF). (2019). A fracture every 3 seconds worldwide - that's osteoporosis. [online] available from prnewswire.com/in/news-releases/iof
-a-fracture-every-3-seconds-worldw
ide-that-s-osteoporosis-88113208
html [accessed April 2020].
Alvaro R, Pennini A. Bone care nurses and the evolution of the nurse’s educational function: the Guardian Angel® research project. Clin Cases Min Bone Metab. 2015; 12(1): 43–48p.
Bartl R, Bartl C. Epidemiology of Osteoporotic Fractures. SpringerLink; 2019.
Thulkar J, Singh S. Overview of research studies on osteoporosis in menopausal women since the last decade. J Mid-life Health. 2015; 6(3): 104–107p.
Sözen T, Özışık L, Başaran NÇ. An overview and management of osteoporosis. Eur J Rheumatol. 2017; 4(1): 46–56p.
Besser SJ, Anderson JE, Weinman J. How do osteoporosis patients perceive their illness and treatment? Implications for clinical practice. Arch Osteop. 2012; 7: 115–124p.
Zhang YP, Li XM, Wang DL, et al. Evaluation of educational program on osteoporosis awareness and prevention among nurse students in China. Nurs Health Sci. 2012; 14(1): 74–80p.
Lai PS, Chua SS, Chan SP. Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis. Int J Clin Pharm. 2013; 35(4): 629–637p.
Solomon DH, Gleeson T, Katz JN. A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial. Osteop Int. 2010; 21(1): 137–144p.
Silverman S, Gold DT. Compliance and persistence with osteoporosis medications: a critical review of the literature. Rev Endocr Metab Disord. 2010; 11(4): 275–280p.
